Clinical Trial Update: Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dapagliflozin and metformin, alone and in combination, for diabetes prevention in overweight/obese women with prior gestational diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gestational Diabetes Mellitus - Long-term Risk Progression to Type 2 Diabetes

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin (metformin)

Snippet

Sponsor: Woman's | Conditions: Diabetes Prevention in Women After GDM Who Are at High-risk | Phase 3 | Status: COMPLETED | Results posted: 2019-04-30